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Considerable experimental evidence exists to prove that the administration 
of the carcinogen dibenzanthracene to the rat results in a decrease of the con- 
tent of vitamin A in the animal's liver (1, 2).  This result is obtained when the 
animal receives either adequate or moderately excessive amounts of the vitamin 
(2),  but the mechanism by which the effect is produced is entirely unknown. 
Recently, however, the possibility has been suggested (3) that a specific hepatic 
protein, to which vitamin A conceivably is bound, is in some manner impaired 
or absent from the liver of the animal which receives the carcinogen. 
This suggestion of damage to a conjugated protein, of which vitamin A forms 
the  prosthetic  group,  may be analogous to the  concept  of Kensler,  Dexter, 
Young, and Rhoads (4, 5).  They demonstrated that the presence of metabo- 
lites of the carcinogen butter yellow prevents in vitro both the diphosphopyr- 
idine nucleotide and cocarboxylase from functioning with their specific  protein 
enzymes in the yeasts used.  This prevention, in turn, can be avoided, within 
limits, by the introduction of excessive amounts of the specific coenzymes into 
the systems.  It is conceivable, therefore, that a similar competitive relation- 
ship might exist in the rat liver between vitamin A and dibenzanthracene--a 
competition for a specific protein, perhaps of enzyme nature, and the success 
in  that  competition dependent upon  the  relative concentrations of the  two 
competing substances. 
On the other hand, since one of the recognized functions of the liver is to 
fabricate, store, and distribute vitamin A  (6),  the impaired hepatic storage of 
the vitamin due to dibenzanthracene feeding also might be explained by the 
production of a general hepatic insufficiency imposed on the organ by the car- 
cinogen.  The  association of a  defective distribution of vitamin A  between 
the  liver and plasma  of patients with gastro-intestinal cancer  (7)  with the 
presence of a generalized hepatic damage in those patients (8) already has been 
demonstrated.  Likewise,  there  is  good  evidence  that  some  patients  with 
hepatic cirrhosis or atrophy have lost, to a considerable extent, their ability to 
store the vitamin (9). 
* The authors wish to acknowledge the kind assistance of the Jane Coffin Childs 
Memorial Fund for Medical Research and Standard Brands, Inc. 
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In view  of these  facts,  it became  desirable to  investigate the  evidence in 
support  of  these  two  possible explanations  for  the  defective  storage  of  the 
vitamin  in  the  dibenzanthracene  treated rat:  (1)  that  the  carcinogen has  a 
specific effect on some liver protein, or other anchor, to which the vitamin nor- 
mally is attached, or (2)  that the carcinogen causes a  general hepatic insuffi- 
ciency and among the functions lost is that of vitamin A  storage.  The results 
of this investigation form the subject of the present report. 
Methods and Materials 
The experiments were carried out on male albino rats of Sherman strain, which had 
an initial weight of from 90 to 110 gin. 
The  standard diet consisted of 8  to 9  gin. of Purina dog chow  (Ralston Purina 
Company) per rat, per day.  1  To this daily ration were added 1 gin. of carrot and 1.5 
gin. of lettuce.  In certain experiments 1.5 gin. of Fleischmann's dried brewer's yeast, 
No. 20-40,  2 were added to the daily diet of each rat. 
Vitamin A was given in the form of a vitamin A concentrate  3 diluted in corn oil so 
that  1 ml. contained 400 u.s.P, units of the vitamin.  The required amount of this 
supplement was administered daily through a  syringe inserted into  the mouths of 
those animals which received the vitamin. 
A 0.1 per cent emulsion of dibenzanthracene  (10)  was injected in doses of 3 rag. 
or 5 rag. at weekly intervals into the peritoneal cavity of those rats scheduled to re- 
ceive the carcinogen.  The total volume of each dose varied from 3 to 5 ml. 
No animal was given either vitamin A supplement or dibenzanthracene until he had 
received the standard diet for 2 weeks in order to make sure that all the rats were in 
good condition and to allow them to become adjusted to their environment.  Urine 
collections were obtained from each group of animals for 5  days before they were 
sacrificed.  During  this  collection period,  the  animals  to  be  killed were  kept in 
metabolism cages. 
All animals were weighed every week.  In general, the nutrition of the control 
animals was found to be well maintained and  their weight increased uniformly at 
about 15 gm. per rat, per week for 12 weeks. 
Animals were sacrificed by decapitation to procure adequate amounts of  blood. 
As soon as possible, the liver of each rat was removed and weighed.  A portion of liver 
of about 600 rag. then was placed in a sealed, tared weighing bottle.  This specimen 
was weighed accurately and homogenized into a brei for chemical determinations. 
In the present study chemical determinations were made of: 
1.  Vitamin A  in the plasma and liver.  The methods used have been described 
previously by the authors (7, 11). 
1 This ration contained from 150 to 170 tl.s.P, units of vitamin A. 
2 The yeast was supplied through the courtesy of the Standard Brands, Inc.  1 gin. 
of yeast contained 520 nag. of protein, 160 ~g. of thiamin, 70/~g. of riboflavin, 60 #g. 
of  pyridoxin, 600  /~g. of  nicotinic acid, and about 650 #g.  of  choline.  It  is  also 
known  to contain appreciable amounts of sulfur amino acids. 
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2.  Total protein, albumin, and globulin of the serum and liver.  4  The technique of 
Robinson et al. (12) was used to measure the protein and its fractions in the serum and 
liver brei. 
3.  The total lipid carbon of the liver.  This was determined by the technique of 
Van Slyke et al.  (13). 
4.  The cholesterol and cholesterol esters of the serum.  These were measured by the 
method of Schoenheimer and Sperry (14). 
5.  Phospholipids of the liver.  The method of Sinclair  (15) was used. 
6.  Riboflavin of the liver.  The technique of Hodson and Norris (16), adapted by 
Kensler et al. (4) for the determination of the vitamin in liver brei was employed. 
7.  The urinary glucuronates.  These were measured by the procedure of Maughan 
et al.  (17). 
8.  The urinary phenol and phenol esters.  The method of Folin and Denis was 
used (18).  The final color developed was read by the Pfalz and Bauer Photoelectric 
colorimeter. 
The  material  now  to  be presented  includes  the  results  of experiments  to 
determine whether the administration of dibenzanthracene to the rat resulted 
in (a) a general hepatic insufficiency, or (b) an isolated effect on a specific liver 
protein (or other anchor) to which vitamin A normally is attached. 
Experiments to Ascertain Whether or Not the Administration  of Dibenzanthracene 
Produces a General Hepatic Insufficiency 
For these experiments a colony of 58 Sherman strain, male, albino rats was used. 
These animals had an initial weight of from 90 to 110 gm.  Mter they had taken the 
standard diet for 2 weeks,  10 nnselected rats were sacrificed in order to ascertain the 
status of the hepatic functions of the animals in the colony. 
Results of Prdiminary  Studies.--At  the time the 10 animals were sacrificed 
their weights ranged from 126 to 140 gin. and averaged 134.5  gm.  The livers 
of these animals weighed from 4.0 to 6.1  gm., and the average weight was 4.9 
gm.  Thus,  the  ratio  of liver weight  to  body weight  ranged  from 0.035  to 
0.039, and the average ratio was 0.037 (Table I). 
The criteria used in this study as measures of normal hepatic function were 
the ability of the liver to (1) maintain a  normal total lipid and phospholipid 
content,  (2)  to store and fabricate albumin,  (3)  to esterify cholesterol,  (4)  to 
synthesize and conjugate glucuronic acid, and  (5) to conjugate phenol.  The 
justification for the use of these criteria is presented in a  later section of this 
communication. 
Accordingly, determinations were made in these and all other animals of this 
colony which subsequently were sacrificed, of the hepatic concentrations of total 
4 By the term liver "albumin" is meant that fraction of the liver protein soluble 
in 22 per cent Na2SO4 at 37°C.; by the term liver "globulin" is meant the total liver 
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lipid, phospholipid, total protein, "albumin," and "globulin."  Likewise, the 
concentrations of protein, albumin, globulin, cholesterol, and cholesterol esters 
were measured in the serum, and the daily excretion of phenol, phenol esters, 
and  glucuronates in  the  urine.  As a  part  of  the  study it  was  necessary to 
determine the levels of vitamin A in the liver and plasma, and likewise desirable 
to measure the riboflavin content of the livers. 
At the end of the 2 week preliminary period, before any of the rats had re- 
ceived vitamin A supplements or carcinogen, it was found that the animals had 
TABLE  I 
The Results of Preliminary Studies Made on Two Groups of Five Unselected Rats of the Colony 
Used in the Present Study 
No. of animals ........................................... 
Body weight, gm .......................................... 
Liver weight, gm  .......................................... 
Average LW/BW  ......................................... 
Hepatic vitamin A, v.s.P,  units per gm ....................... 
Hepatic total lipid carbon,  gin. per cent ...................... 
Average hepatic phospholipid,  gm. per cent ................... 
Average hepatic total protein, gin. per cent ................... 
Average hepatic albumin, gin. per cent ....................... 
Average hepatic globulin, gin. per cent ....................... 
Average 
Average 
Average 
Average 
Average 
Average 
Average 
hepatic riboflavin, ug. per cent ....................... 
plasma vitamin A, v.s.P,  units per 100 ml  ............. 
total serum cholesterols, rag.  per cent ................ 
cholesterol esters/total cholesterol, per cent ........... 
urinary output of glucuronates,  rag. per rat,  per day... 
urinary output of total phenol, rag. per rat, per day .... 
urinary output of phenol esters, rag.  per rat, per day... 
Group I  Group II 
5  5 
126-140  126-136 
4.0-5.1  4.1-5.8 
0.039  0.035 
20.6-34.7  22.6-36.7 
4.45-7.5  4.5-7.0 
2.54  2.60 
15.75  15.55 
2.1  2.2 
13.65  13.35 
16.6  24.2 
0  0 
115  100 
71  69 
2.4  2.7 
3.0  3.2 
0.9  1.0 
hepatic  concentrations  of  vitamin  A  which  ranged  from  20.6  to  36.7,  and 
averaged 28.5  v.s.P, units per gm. of wet liver.  No vitamin A  was found in 
the plasma of these rats at this time (Table I). 
The total lipid in the livers of this group varied from 4.45 to 7.5 gm., and averaged 
6.2 gm. per cent.  The phospholipid content of the pooled liver breis of 2 groups of 5 
animals each was measured and found to range from 2.54 to 2.60 gm. per  cent, the 
average was 2.58 gm. per cent.  Also, the total protein, "albumin," and "globulin" 
concentrations of the livers were measured in the pooled breis of 2 groups of 5 animals 
each.  The contents of total protein varied from 15.55 to 15.75 gm. per cent, of "albu- 
min" from 2.1  to 2.2 gm. per cent, and of "globulin" from 13.35 to 13.65 gm. per cent. 
The concentrations of riboflavin in these 2 pooled breis varied from  16.6  to  24.2  /zg. 
per gm. of wet liver. ABELS, GORHAM, EBERLIN, HALTER~ AND RHOADS  147 
The levels of total serum cholesterols ranged from 100 to 115 mg. per cent, of which 
the esters formed from 69 to 71 per cent (Table I).  At this time the concentrations 
of total protein, albumin, and globulin  in the serum were not determined. 
The urinary excretions of glucuronates varied from 2.40 to 2.70 mg. per rat, per 
day, over a 5 day test period.  The daffy urinary outputs of total phenol ranged from 
3.0 to 3.2 mg. per rat, and that of phenol esters from 0.9 to 1.0 mg. (Table I). 
Mter these basal data had been obtained, the remainder of the colony was divided 
into 4 equal groups of 12 animals each (A, B, C, D).  All were maintained on the 
standard  diet.  The animals of group A  received the  diet  alone and acted as the 
controls for the experiment, group B  received,  in  addition  to  the  diet,  200  u.s.P. 
units  of  vitamin  A  per rat,  per day,  each  animal of group  C  was given every 
week 3 mg. of dibenzanthracene intraperitoneaUy, and the rats in group D  received 
not only the 3 mg. dose of the carcinogen each week, but also the 200 u.s.1,, units  of 
the vitamin each day. 
Four unselected animals of each of the 4 groups were sacrificed at the end 
of 4, 8, and 12 weeks after the preliminary results had been obtained.  At these 
times studies were made to ascertain the effect of the carcinogen on the growth 
of the animals, on their hepatic functions, and on their ability to store vitamin 
A.  Likewise, measurements were made of the riboflavin contents of the livers. 
Results after the Administration of Dibenzanthracene,  Vitamin A, or Both.-- 
(a) Rate of Growth: The animals which received the carcinogen showed a definite 
retardation of growth.  Whereas the rats of groups A and B during the first 4 
weeks showed an average weight gain per week of about 20 gin., and of from 
9 to 14 gm. during the next 4 weeks, those of groups C and D  gained only 11 
grn. during the first, and from 5.5 to 9.75 gin. during the second 4 week period. 
This growth retardation was more prominent in the rats which received the 
carcinogen alone, for during the third 4 week period the animals of this group 
actually lost weight, whereas those of the other 3 groups remained at relatively 
stable levels (Table II). 
(b) Liver Weight and Ratio of Liver Weight to Body Weight (LW/BW):  The 
average liver weights of groups C and D  at all times were about 2 gm. heavier 
than those of groups A and B, and after the 4th week, the livers of the rats of 
group D  were even larger than  those  of group  C.  When  the  average liver 
weight of each group was divided by the average body weight of that group, a 
ratio was obtained which emphasized particularly the fact that  the adminis- 
tration of the carcinogen had produced a hepatomegaly.  Thus, at the end of 
the 4, 8, and 12 weeks, the ratios of LW/BW for groups A were 0.035, 0.032, 
0.022 respectively; and for group B, 0.036, 0.025, and 0.028.  In sharp distinc- 
tion were the values for group C of 0.052, 0.040, and 0.046, and also those for 
group  D,  of 0.050,  0.041,  and 0.045.  It is  to  be  noted  that  no  significant 
difference existed between the comparable values for groups A  and B, or be- 
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(c)  The Concentrations of Vitamin A  in the Liver: The effect of the adminis- 
tration of dibenzanthracene  on the hepatic store of vitamin A is essentially that 
obtained by Goerner (1) and by Baumann (2, 3).  Even at the end of 4 weeks, 
when each of the rats of groups C and D  had received only 12 mg. of the car- 
TABLE II 
The Average Body Weight of the Rats on the Basal Diet and of Those Which Received Supplements 
of Vitamin A and of Dibenzanthracene 
Group 
A 
B 
C 
D 
At the end of 
4 wks.  8  wks. 
gm.  gm. 
210  265 
213  250 
181  213 
179  218 
12 wks. 
gm. 
270 
245 
170 
210 
Group A received basal diet alone; group B received diet and 200 u.s.P, units of vitamin 
A per rat, per day; group C received diet and 3 mg. of dibenzanthracene per rat, per week; 
group D received diet and 200 u.s.P, units of vitamin A per rat, per day, and 3 mg. of di- 
benzanthracene per rat, per week. 
TABLE m 
The Average Liver Weight and Ratios of Liver Weights to Body Weights of the Rats on the Basal 
Diet and o r Those Which Received Supplements of Vitamin A and of Dibenzanthracene 
At the end of 
Group  4 wks.  8 wks.  12 wks. 
A 
B 
C 
D 
Liver weight  LW/BW 
gm. 
7.4  0.035 
7.6  0.036 
9.6  0.052 
9.3  0.050 
Liver weight  LW/BW 
g~. 
8.6  0.032 
6.3  0.025 
9.75  0.040 
11.2  0.041 
Liver weight  LW/BW 
gm. 
6.05  0.022 
6.8  0.028 
7.9  0.046 
9.5  0.045 
Group A received basal diet alone; group B received diet and 200 u.s.P, units of vitamin A 
per rat, per day; group C received diet and 3 mg. of dibenzanthracene per rat, per week; 
group D received diet and 200 u.s.P, units of vitamin A per rat, per day, and 3 rag. of di- 
benzanthracene per rat, per week. 
cinogen, significant decreases in their hepatic concentrations of vitamin A were 
noted.  The average hepatic content of the vitamin of group A was 266 v.s.P. 
units; of group B,  (which had received 200 u.s.P, units of vitamin A  per rat 
per day) 404 u.s.P, units; of group C, 104 u.s.P, units; and of group D  (which 
had received both carcinogen and 200 u.s.P, units of vitamin A  per rat,  per 
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A  consistent increase in the average hepatic concentration of vitamin A  in 
all instances was associated with the increased age and weight of the animals. 
Nevertheless,  the hindrance to vitamin A  storage which the dibenzanthracene 
imposed upon the livers was a  constant finding.  At the end of 8 weeks,  the 
average hepatic concentrations of the animals sacrificed from groups A, B, C, 
and D  respectively were 1192, 1788, 479, and 306 u.s.P, units per gin., and those 
sacrificed at the end of 12 weeks, 2560, 2475, 645, and 554 u.s.e, units per gm. 
At the end of the 4 and 8 week periods, the daily administration of 200 u.s.P. 
units of vitamin A  to the rats of group B had increased the hepatic  concentra- 
TABLE IV  TABLE V 
The  Average  Concentration  of  Vitamin  A  The Average  Concentration  of Vitamin  A 
in  the  Livers  of the  Rats  on  the  Basal  in the Plasma of the Rats on the Basal 
Diet  and  of  Those  Which  Received  Diet  and  of  Those  Which  Received 
Supplements  of  Vitamin  A  and  of  Supplements  of  Vitamin  A  and  of 
Dibenzanthracene  Dibenzanthracene 
Group 
At the end of 
4 wks. 
U.S.!Q. units 
per gra. 
A  266 
B  404 
C  104 
D  190 
8 wks. 
u.s.P,  units 
per gin. 
1192 
1788 
479 
306 
12 wks. 
Group 
U.s.P. units 
per gra. 
2560  A 
2475  B 
645  C 
554  D 
Group A received basal diet alone; group 
B received diet and 200 u.s.v, units of vita- 
min A per rat, per day; group  C received 
diet and 3 mg. of dibenzanthracene per rat, 
per week; group D  received diet and 200 
u.s.P, units of vitamin A per rat, per day 
and 3 mg. of dibenzanthracene  per rat, per 
week. 
At the end of 
4 wks. 
o.s.P, units 
per I00 ml. 
125 
155 
2O2 
219 
8 wks. 
u.s,P, units 
per 100 ml. 
95 
160 
77.5 
143.5 
12 wks. 
U.S.P. units 
per 100 ml. 
200 
175 
150 
310 
Group A received basal diet alone; group 
B received diet and 200 •.s.v.  units of vita- 
min A per rat, per day; group  C received 
diet and 3 rag. of dibenzanthracene per rat, 
per week; group D  received diet and 200 
v.s.v, units of vitamin  A per rat, per day, 
and 3 mg. of dibenzanthracene  per rat, per 
week. 
tions of the vitamin over those of group A.  In contrast to this finding, it was 
noted that the administration  of an equal amount of vitamin A  to the rats of 
group D  increased the hepatic levels of the vitamin over those of group C only 
until the end of the 4th week, and that thereafter, with the continued injections 
of dibenzanthracene,  no increased  stores  of the  vitamin  could be effected in 
the rats of group D. 
In  summary,  therefore,  it  would  appear  that  the  ingestion  of vitamin  A 
supplements temporarily increased the hepatic store of the vitamin,  and that 
the parenteral administration of the carcinogen hindered the establishment  of 
this  store  both  in  animals  taking  a  normal  diet  and in those  fed  200 u.s.v. 
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(d)  The Concentrations of Vitamin A  in the Plasma:  At the end of the 4th 
week the average plasma levels of vitamin A in groups A, B, C, and D  in that 
order  were  125,  155,  202,  and  219  tr.s.1,, units  per cent.  The ingestion of 
vitamin A  supplements was reflected in its increased plasma levels of groups 
B  and D,  over those of groups A and C respectively (Table V). 
The average concentration of the vitamin in the plasma of the group D  rats 
remained higher than that of the group C animals throughout the experiment, 
probably due  to  the  continued administration  of the  vitamin  supplements. 
This relationship, however, did not persist between the animals of groups A 
and B whose liver concentrations of vitamin A had increased considerably as 
the experiment continued.  A  lack of correlation between the plasma  levels 
of vitamin A in rats with normal and abnormally high hepatic concentrations 
of the vitamin has been found by others (19). 
It is of interest to note that after the 4th week the levels of vitamin A in the 
plasma of groups C and D  were no longer correspondingly higher than those 
of groups A and B. 
(e) Total Lipid Carbon and Phospholipid Content of the Liver: The concentra- 
tions of total lipid carbon in the livers of the animals which received the car- 
cinogen were not abnormally increased at the end of the 4th week.  The aver- 
age hepatic contents of total lipid carbon of groups A and B were 5.5 and 9.8 
gin. per cent respectively, whereas those of groups C and D were 6.4 and 6.8 gin. 
per cent respectively.  The average concentrations obtained for the livers of 
groups A, B, C, and D  in that order at the end of 8 weeks were 8.8, 9.3, 10.6, 
and 7.4 gin. per cent; and at the end of 12 weeks 6.5, 5.5, 7.5, and 6.6 gm. per 
cent (Table VI). 
This failure to find any significantly altered total lipid carbon content in the 
rivers  of  the  rats  which  received dibenzanthracene  is  compatible  with  the 
relatively constant concentration of phosphoripid in those organs.  For groups 
A, B, C, and D, respectively, the hepatic concentrations of phospholipid were 
at the end of 4 weeks 2.7, 2.7, 2.85, and 2.25 gm. per cent; at the end of 8 weeks 
3.0, 2.8, 3.1, and 2.95 gm. per cent; and at the end of 12 weeks 2.65,  2.8, 2.9, 
and 2.75 gm. per cent (Table VI). 
(f  ) TheConcentrations of Total Protein, "Albumin," and" Globulin" in the Liver: 
No consistently significant changes in the concentrations of hepatic protein or 
the two fractions were noted in the groups of animals studied.  At the end of 
the 4th week, the concentrations of liver total proteins were for groups A, B, 
C,  and  D  15.4,  14.6,  13.95,  and  14.65  gm.  per cent respectively.  The low 
value of 13.9 gin. per cent of group C was due to a  decrease in the "globulin" 
fraction.  The average concentrations of "globulin" at this time were for groups 
A, B, C, and D  respectively 13.7,  12.9,  12.1, and 12.9 gm. per cent, and those 
of "albumin" 1.7, 1.7, 1.85, and 1.75 gin. per cent (Table VII). 
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"globulin" in the livers of the group  C  rats were found to be within the limits 
of normal.  The  average  values found for total  liver  protein at  the  end  of 8 
TABLE VI 
The Average  Concentrations of Total Lipid Carbon and of Phospholipid in the Livers of the Rats 
on the Basal Diet and of Those Which Received Supplements of Vitamin A  and 
of Dibenzanthracene 
At the end of 
Group  4 wks.  8 wks.  12 wks. 
Total lipid  Phospholipid 
carbon 
A 
B 
C 
D 
Total lipid  Phospholipid  carbon 
gm. per cent  gm. per cent 
5.5  2.7 
9.8  2.7 
6.4  2.85 
6.8  2.25 
Total lipid  Phospholipid  carbon 
gin. per cent  gin. per cent 
8.8  3.0 
9.3  2.8 
10.6  3.1 
7.4  2.95 
gin. per cent 
6.5 
5.5 
7.5 
6.6 
gra.  per cent 
2.65 
2.8 
2.9 
2.75 
Group A received basal diet alone; group B received diet and 200 v.s.p, units of vitamin A 
per rat,  per day;  group  C  received diet and 3  mg.  of dibenzanthracene  per rat,  per week; 
group D received diet and 200 u.s.P,  units of vitamin A per rat, per day, and 3 rag.  of dibenz- 
anthracene per rat, per week. 
TABLE VII 
The Average  Concentrations  of Total Protein, "Albumin," and "Globulin" in the Livers of the 
Rats on the Basal Diet and of Those Whick Received Supplements of Vitamin A  and 
of Dibemanthracene 
At  the end of 
4 wks.  8 wks.  12 wks.  Group 
A 
B 
C 
D 
Total 
protein 
per ce.a 
15.4 
14.6 
13.95 
14.65 
Albu  - 
min" 
ef ten 
1.7 
1.7 
1.85 
1.75 
"Globu- 
lin" 
gm. 
per cent 
13.7 
12.9 
12.1 
12.9 
Total 
protein 
gm. 
per cent 
16.75 
18.3 
18.45 
14.9 
Ibu- 
in" 
m. 
c~t 
.55 
.7 
.85 
.1 
Globu-  Total 
liu"  protein 
e;'~;., [ d~;n' 
14.2  [  19.0 
15.6  ]  18.65 
15.6  18.7 
12.8  ]  19.2 
"Albu- 
Inin ~' 
gm. 
~er cent 
4.1 
3.75 
3.8 
3.6 
"Globu- 
lin" 
gm. 
per cent 
14.9 
14.9 
14.9 
15.6 
Group A received basal diet alone; group B received diet and 200 u.s.P,  units of 
per rat,  per day; group C  received diet and 3 mg. of dibenzanthracene  per rat, 
group D received diet and 200 u.s.P, units of vitamin A per rat, per day, and 3 mg. 
anthracene per rat, per week. 
vitamin A 
per week; 
of dibenz- 
weeks for groups A, B, C, and D  in that order were 16.75,  18.3,  18.45, and  14.9 
gm. per cent, and at the end of 12 weeks 19.0, 18.65,  18.7, and 19.2 gm. per cent. 
The average concentrations  of "albumin"  at  the end of 8 weeks were 2.55, 2.7, 
2.85,  and  2.1  gm.  per cent and  at  the end of  12  weeks 4.1,  3.75,  3.8,  and  3.6 152  HEPATIC VITAMIN A 
gm. per cent for groups A, B, C, and D  respectively.  Finally, at the end of 
8 weeks,  the average hepatic  contents of "globulin" were  14.2, 15.6, 15.6, and 
12.8 gm. per cent, and at  the end of 12 weeks 14.9, 14.9, 14.9, and  15.6 gm. per 
cent!for groups A, B, C, and D  respectively. 
(g)  The Concentrations of Total Protein, Albumin, and Globulin in the Serum: 
Likewise,  no evidence of a  significant  hypoproteinemia  or hypoalbuminemia 
was found in the animals which were injected with dibenzanthracene.  During 
the  12 weeks of this  experiment,  the average total serum protein of group A 
varied from 6.2 to 7.2 gm. per cent; of group B  from 6.0 to 7.1 gin. per cent; 
of group C from 6.1 to 6.9 gm. per cent; of group D  from 6.0 to 7.3 gm. per cent. 
TABLE VIII 
The Average Concentrations of Total Protein, Albumin,  and Globulin in the Serum of the Rats 
on the Basal Diet and of Those Which Received Supplements of Vitamin A and 
of Dibenzanthracene 
At the end of 
4 wks.  8 wks.  12 wks.  Group 
A 
B 
C 
D 
Total 
protein 
gm. 
per cent 
7.2 
7.1 
6.9 
7.3 
Albumin 
grtt. 
per cent 
4.0 
4.4 
3.9 
4.3 
Globulin 
gm. 
per cent 
3.2 
2.7 
3.0 
4.0  I 
Total 
protein 
gm, 
per cent 
6.2 
6.0 
6.1 
6.0 
Albumin 
gm. 
per cent 
3.9 
3.6 
3.6 
3.4 
Globulin 
gm. 
#er cent 
2.3 
2.4 
2.5 
2.6 
Total 
protein 
gm. 
t~er cent 
6.8 
6.4 
6.4 
6.75 
Albumin 
gm, 
per cent 
4.9 
5.4 
5.5 
5.7 
Globulin 
gm. 
per cent 
1.9 
1.0 
0.9 
1.05 
Group A received basal diet alone; group B received diet and 200 tl.s.v, units of vitamin A 
per rat, per day; group C received diet and 3 mg. of dibenzanthracene per rat, per week; group 
D received diet and 200 v.s.P, units of vitamin A per rat, per day, and 3 mg. of dibenzanthra- 
cene per rat, per week. 
The average concentration of serum albumin of group A  varied from 3.9 to 4.9 
gin. per cent; of group B  from 3.6 to 5.4 gm. per cent; of group C  from 3.6 to 
5.5 gm. per cent; and of group D  from 3.4 to 5.7 gm. per cent (Table VIII). 
Furthermore,  the  average  ratios  of albumin  to  globulin  in  the  serum  of 
groups C  and D  were not significantly lower than  those  of groups A  and B. 
These values for groups A, B, C, and D  in that order were at the end of 4 weeks 
1.25, 1.63, 1.30, and 1.43; at the end of 8 weeks,  1.70,  1.50,  1.44, and 1.31; and 
finally at the end of 12 weeks, 2.46, 5.40, 6.34, and 5.43.  The concentrations 
of globulin in the serum of the four groups varied considerably and accordingly 
these variations were reflected in the wide fluctuation of the A/G ratios. 
(h)  The Ratios  of the Concentration  of Esterified  to  Total  Cholesterol  in  the 
Serum: At no time were the ratios of esterified to total cholesterol abnormally 
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animals of groups C and D had each received the dibenzanthracene for 4 weeks, 
these ratios were 70 and 75 per cent respectively, whereas those for groups A 
and B were 75 and 70 per cent respectively.  Again, at the end of 8 weeks, the 
ratios for groups A, B, C, and D  in that order were 86, 84, 71, and 85 per cent; 
and at the end of 12 weeks 73, 62, 66, and 72 per cent (Table IX). 
(i) The Daily Urinary Excretion of Glucuronates, and of Total and Conjugated 
Phenols: The urine was collected from each group of animals for 5 days during 
the 4th, 8th, and 12th weeks of the experiment.  Determinations of the daily 
output  of glucuronates,  however,  were  made  only during  the  4th  and  12th 
weeks, and at those times no significantly abnormal decrease in the amounts 
excreted by groups C  and D  were found.  During the 4th week, the animals 
TABLE  IX 
The Average Concentrations of Free and Esterified Cholesterol  in the Serum of the Rats on the 
Basal Diet and of Those Which Received Supplements  of Vitamin A  and of 
Dibenzanthracene 
Group 
A 
B 
C 
D 
At the end of 
4 wks. 
Free  Esters 
rag.  per cent  rag. per cent 
30  77.5 
34  79 
22  103 
30  92 
8 wks. 
Free  Esters 
rag. per cent  rag. per cent 
11  68 
13  68 
20  50 
13  75 
12 wks. 
Free  Esters 
rag. per cent  rag.  per cent. 
23  60 
33  53 
31  61 
24  63 
Group A received basal diet alone; group B received diet and 200 v.s.P, units of vitamin A 
per rat, per day; group C received diet and 3 mg. of dibenzanthracene per rat, per week; group 
D received diet and 200 v.s.P, units of vitamin A per rat, per day, and 3 rag. of dibenzan- 
thraeene per rat, per week. 
of groups A, B, and C excreted 4.5 rag. per rat per day, and those of group D 
5.0 rag. per rat per day.  During the 12th week, group A excreted 4.0 mg. per 
rat per day, group B  5.5 rag., group C 5.0 mg., and group D  4.25 rag. per rat, 
per day. 
During the periods of collection the daily excretion of total and of conjugated 
phenol by the animals in groups C  and D  were within the limits of those ex- 
creted by the rats which did not receive the carcinogen.  The urinary output 
of total phenols by groups A, B, C, and D  respectively were 2.8, 4.0, 3.2, and 
3.3 rag. per day during the 4th week; 4.1, 1.9, 4.7, and 3.55 rag. per day during 
the 8th weeks; and 3.8,  3.1,  4.2,  and 3.8 mg. per day during the  12th week. 
Furthermore, the degree of phenol conjugation by the rats of groups C and D 
during these periods were at all times within the normal limits.  The ratio of 
the outputs of total to conjugated phenol of groups A,  B,  C, and D  in that 154  HEPATIC VITAM'I'N  A 
order were 23, 26, 30, and 24 per cent in the 4th week; 33, 22, 23, and 24 per 
cent in the 8th week; and 34, 34, 37, and 37 per cent in the 12th week (Table X). 
(j)  The Concentration of Riboflavin in the Liver:  Goerner has demonstrated 
TABLE X 
The Average Excretion of Glucuronates, Total Phenol, and Phenol Esters in the  Urine of the 
Rats in the Basal Diet and of Those Which Received Supplements of Vitamin A and 
of Dibenzanthracene 
During the  course  of  the 
Group  4th wk.  8th  wk.  12th  wk. 
A 
B 
C 
D 
3lucuro- 
nates 
reg.~rat 
per day 
4.5 
4.5 
4.5 
5.0 
Total 
phenol 
rag./rat 
per day 
2.8 
4.0 
3.2 
3.3 
Phenol 
esters 
mg./ra~ 
per day 
0.6 
1.05 
1.0 
0.8 
Total  ~henol 
phenol  ~sters 
mg./rat  ~g./rat 
per day  ,er day 
4.1  1.7 
1.9  0.4 
4.7  1.1 
3.55  0.85 
Glucuro  - 
nstes 
reg.~rat 
per day 
4.0 
5.5 
5.0 
4.25 
Total 
phenol 
~g.lrat 
per day 
3.8 
3.1 
4.2 
3.8 
Phenol 
esters 
rag./rat 
per day 
1.3 
1.05 
1.6 
1.4 
Group A received basal diet alone; group B received diet and 200 u.s.P, units of vitamin A 
per rat, per day; group C received diet and 3 rag. of dibenzanthracene per rat, per week; 
group D received diet and 200 u.s.P, units of vitamin A per rat, per day, and 3 rag. of diberLz- 
anthracene per rat, per week. 
TABLE  XI 
The Average Concentration of Riboflavin in the Livers of the Rats on the Basal Diet and of These 
Which Received Supplements of Vitamin A and of Dibenzanthracene 
At the end of 
Group 
4 wks.  8 wks.  12 wks. 
A 
B 
C 
D 
/*g. 
17 
17 
15 
15 
~g. 
30 
33 
30.5 
29 
t~g. 
34 
30 
28 
30 
Group A received basal diet alone; group B received diet and 200 u.s.v, units of vitamin A 
per rat, per day; group C received diet and 3 rag. of dibenzanthracene per rat, per week; 
group D received diet and 200 u.s.P, units of vitamin A per rat, per day, and 3 rag. of dibenz- 
anthracene per rat, per week. 
that whereas the administration of dibenzanthracene to the rat depletes and 
prevents the establishment of the hepatic store of vitamin A, the carcinogen is 
without effect upon the concentrations of vitamin C  in the liver (1).  To in- 
vestigate further the possibility that the primary effect of the dibenzanthracene 
is on the hepatic store of vitamin A, determinations were made of the concen- 
trations of riboflavin in the livers of the animals studied. ABELS~ GORHAM, EBERLIN~ HALTER, AND RHOADS  155 
At the end of the 4th week of the experiment, the hepatic concentrations of 
riboflavin were for groups A, B, C, and D respectively 17,  17,  15, and  15  vg. 
per grn. wet weight.  At the  end  of  the  8th  week,  the  average concentra- 
tions were  30,  33,  30.5,  and  29  ~g.  per  gin.,  and at the  end  of  the  12th 
week, 34, 30, 28, and 30 ~g. per gm. wet weight for  groups  A,  B,  C,  and  D 
respectively (Table XI). 
Thus, it would appear that  the administration  of the carcinogen  depletes 
neither the hepatic store of vitamin C nor that of vitamin B2. 
The evidence at hand indicates, therefore, that the parenteral administration 
of dibenzanthracene to rats does produce an hepatomegaly but not a general 
hepatic insufficiency.  This conclusion is based upon the observation that the 
rats which received the carcinogen did not have any significant fatty infiltra- 
tion of their livers nor abnormally low hepatic content of phospholipids.  The 
livers contain  normal  amounts  of  "albumin"  and make  normal amounts  of 
serum albumin, esterify normal amounts of  cholesterol and phenol, and syn- 
thesize and conjugate normal amounts of glucuronic acid.  Furthermore, the 
administration of the carcinogen to the rats does not impair the ability of their 
livers to store all vitamins, since such livers retain normal  concentrations of 
riboflavin and  of vitamin  C  (1). 
Experiments to Ascertain Whether or Not a Competition Exists Between Diben- 
zanthracene  and  Vitamin  A  for  the  Storage  of  the  Vitamin  in  the  Liver 
From the  data presented it would appear that  the injection of dibenzan- 
thracene  into  the  rat  in  some  manner  impairs  the  ability of vitamin  A  to 
remain in  the liver.  A  similar  situation has  been found to exist when the 
carcinogen, butter yellow, is fed to the rat  (4).  The  administration of this 
carcinogen decreases the hepatic stores  of diphosphopyridine nucleotide and 
of riboflavin.  Furthermore, the introduction of certain metabolites of butter 
yellow into a  suspension of yeast apozymase has been shown to reduce  the 
activity  of  diphosphopyridine  nucleotide,  a  derivative  of  nicotinic  acid, 
probably by blocking the nucleotide from its attachment to its specific enzyme 
(20).  This block, however, can be prevented in vitro by the introduction into 
the system of excess amounts of the nucleotide.  This fact suggests the exist- 
ence  of  a  competition in vitro  between the metabolite of butter yellow  and 
the diphosphopyridine nucleotide for the specific enzyme protein, and perhaps 
a similar competition exists in the liver of the animal fed butter yellow.  Hence, 
should it be possible to demonstrate that  the ability of dibenzanthracene to 
reduce the liver content of vitamin A  could be prevented by the simultaneous 
administration of excess amounts of  vitamin A,  then it would be reasonable 
to  assume  the  existence of a  similar  competition between dibenzanthracene 
and vitamin A for the storage of the  vitamin.  Furthermore, it would appear 156  REPATIC  VITAMIN  A 
that the presence of dibenzanthracene, or its metabolites,  specifically impairs 
the means by which vitamin A is anchored in the liver. 
Accordingly, this hypothesis was subjected to a  simple experiment.  Four 
groups of Sherman strain rats, E, F,  G, and H, whose initial weights varied 
from 85 to 105 gm. were placed on the same diet as that given the animals in 
the  previous  experiment.  Each  rat  received at  weekly  intervals  3  mg.  of 
dibenzanthracene  intraperitoneally  for  8  weeks.  Group  E  consisted  of  21 
animals  which  received only the  diet and  the  carcinogen.  Group  F,  of  10 
animals, received in addition an oral supplement of 200 v.s.1,, units of vitamin 
A per rat, per day.  Group G, of 11 animals, received an oral supplement of 
400 u.s.P,  units  of vitamin A  per rat, per  day.  Finally,  the  11  animals  of 
Group H received no supplements of vitamin A, but instead 1.5 gm. of Fleisch- 
mann's  brewers'  yeast each day.  This last  group was included in order to 
determine whether or not the administration of a crude supplement of the B 
vitamins and choline also might not counteract the effect of the carcinogen on 
the hepatic store of vitamin A. 
At the end of the 8th week of this experiment, 5 unselected rats of each group 
were sacrificed and determinations made of their hepatic and blood levels of 
vitamin A.  The average hepatic concentration of the vitamin of groups E, 
F,  G, and H  respectively were 750,  1125,  1560, and 394 u.s.P, units per gin. 
wet weight (Table XII).  Thus, the values obtained for groups E, F, and G 
indicated at once that the simultaneous administration of increasing amounts 
of vitamin A exerted a graded countereffect on the ability of dibenzanthracene 
to impair the hepatic storage of this vitamin.  Indeed, this countereffect was 
noted in the previous experiment at the end of the first 4 week period.  At 
that time the average vitamin A in the livers of the rats which had received the 
carcinogen alone (group C) was  104 u.s.P, units per gin., whereas that of the 
animals which received both the carcinogen and 200 u.s.P, units of vitamin A 
daily was 190 u.s.1,,  units per gm.  In the previous experiment, however, this 
relationship no longer existed at the end of the 8th or 12th  weeks.  Why the 
daily administration of  200 u.s.1,,  units of vitamin A  in the first experiment 
counteracted the effect of dibenzanthracene for 4 weeks but not for 8 weeks, 
whereas it still did so in the second, cannot be explained at this time. 
In this second experiment, at the end of 8 weeks the average levels of vitamin 
A in the plasma of groups E, F, G, and H respectively were 183, 300, 400, and 
160  u.s.P,  units per cent.  For groups E, F,  and G  these increasing plasma 
levels probably reflected only the corresponding increase in the hepatic con- 
centration of the vitamin (19) (Table XIII). 
It is to be noted that the average concentration of the vitamin in both the 
liver and plasma  of the animals which received yeast  (group H)  were even 
lower than those of group E.  The animals of the former group had received no 
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Since it was found that the administration of excess amounts of vitamin A 
could counteract the ability of dibenzanthracene to impair hepatic storage of 
the vitamin, it was next desirable to determine whether or not the injection of 
larger amounts of the carcinogen, in turn,  could counterbalance  the  "protec- 
tive" effects of the vitamin A  supplements.  Should such a  counterbalance be 
demonstrated, then the hypothesis that a  competition exists between the car- 
cinogen and vitamin A for the hepatic storage of the vitamin would have some 
further support. 
TABLE XII 
The Average  Concentration  of Vitamin A  in 
the Livers of the Rats Which Received 
Dibenzanthracene  and Supplements 
of Vitamin A  or Yeast 
Group 
E 
F 
G 
H 
At the end of 
8 wks.  12 wks. 
u.s.P, units  ~.s.P. units 
per gin.  per gin. 
750  685 
1125  664 
1560  898 
394  228 
TABLE XIII 
The Average Concentration  of Vitamin A  in 
the Plasma of the Rats Which Received 
Dibenzanthracene  and Supplements 
of Vitamin A  or Yeast 
Group 
E 
F 
G 
H 
At the end of 
8 wks.  12 wks. 
U.S.P. units  U.S.P. unil$ 
per I00 ral.  per I00 rat. 
183  288 
300  300 
400  250 
160  275 
Group E received basal diet and 3 mg. 
of dibenzanthracene per rat, per week for 8 
weeks and 5 mg.  of dibenzanthracene per 
rat,  per  week  thereafter.  Group  F  re- 
ceived, in addition, 200 v.s.P, units of vita- 
min A per rat, per day; group G received 
400 u.s.P,  units per rat, per day; group H 
received 1.5 gin. of yeast per rat, per day. 
Group E received basal diet and 3 mg. 
of dibenzanthracene per rat, per week for 8 
weeks and 5 rag. of dibenzanthracene per 
rat,  per  week  thereafter.  Group  F  re- 
ceived, in addition, 200 v.s.P, units of vita- 
min A per rat, per day; group G received 
400 v.s.P, units per rat, per day; group H 
received 1.5 gm. of yeast per rat, per day. 
In an attempt to provide this evidence the remaining animals of groups E, F, 
G, and H  were given weekly injections of 5, instead of 3, mg. of dibenzanthra- 
cene.  At the end of  12  weeks,  after 4  of the larger injections had been ad- 
ministered to each rat,  all of the animals were  sacrificed and determinations 
made of vitamin A in their livers and plasma. 
Previously it had been demonstrated that at the end of the 8th week the daily 
ingestion of 200 (group F) and 400 (group G) TJ.S.p. units of vitamin A  by rats 
which  received  only  3  mg.  of  dibenzanthracene  weekly had  increased  their 
average hepatic concentrations of the vitamin by 50 and by 108 per cent re- 
spectively over that found in the control group (E).  However, after the weekly 
dose of carcinogen had been raised to 5 mg., the average hepatic concentration 
of the vitamin had fallen in groups E, F, G, and H  respectively to 685,664, 898, 158  HEPATIC VITAMIN A 
and  228 o.s.P,  units per gm.  wet weight.  Thus,  the daily ingestion of 200 
tT.s.r, units of vitamin A by the rats which received 5 mg. of the carcinogen no 
longer was able to increase the hepatic store of the vitamin, and the daily in- 
gestion of 400 u.s.P, units by these animals was able to effect only an increased 
hepatic  concentration of vitamin A  of 31  per  cent instead  of  108  per  cent 
(Table XII). 
Hence, the ability of the dibenzanthracene to interfere with the storage of 
vitamin A by the liver not only can be counteracted by the simultaneous ad- 
ministration of an excess of vitamin A, but this counteraction, in turn, can be 
overcome  by  the  addition  of  larger  amounts  of  the  carcinogen.  Such  a 
relationship  indicates  the  possible  existence  of  a  competition  between 
vitamin A  and dibenzanthracene, for some component of the liver, possibly 
protein, with which vitamin A  normally is conjugated.  The success in this 
competition apparently depends upon the relative concentrations of the two 
competing substances. 
At the end of the 12th week, when each rat had received 8 injections of 3 rag. 
of dibenzanthracene, and 4 injections of 5 rag. of the carcinogen, the average 
plasma levels of the vitamin of groups E, F, G, and H  were 288, 300, 250, and 
275 u.s.P, units.  There appears to be no obvious correlation between these 
levels and those of the livers of the corresponding groups (Table XIII). 
It is of interest to note that the average hepatic concentration of vitamin A in 
the animals which received the supplements of yeast (group H) remained sig- 
nificantly lower than even that of the control group E.  Thus, it would appear 
that the simultaneous administration of yeast to the dibenzanthracene treated 
rat certainly does not protect the animal from the effects of the carcinogen on 
the hepatic storage of vitamin A. 
DISCUSSION 
In the present study an attempt has been made to ascertain whether the 
ability of dibenzanthracene to impede the storage of vitamin A by the rat liver 
is due to a general hepatic insufficiency caused by the carcinogen or to an im- 
pairment of a  specific function of the liver.  Inasmuch as the liver performs 
multiple functions, it is reasonable to believe that no single test could measure 
adequately the efficiency of the whole organ.  Therefore, by the quantitative 
measurement of various intermediary or end products of liver metabolism, and 
then by the consideration of the results as a whole, it was felt that the presence 
or absence  of general hepatic  damage  could be  recognized.  In  this  study, 
measurements of liver function were selected arbitrarily and thus it is necessary 
to consider the evidence which would indicate that the tests employed in this 
study provided adequate indices. 
1.  The Hepatic Concentration of Total Lipid and Phospholipid.--It is now a 
well established fact that the liver is concerned intimately in the intermediary 
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damage there occurs a striking accumulation of fat in the liver ceils.  An in- 
crease in the concentration of neutral fat and a decrease of phospholipids  has 
been found especially in the livers of patients with alcoholic hepatic cirrhosis 
(22), and in animals given various toxic agents (23). 
2.  Total Protein, Albumin, and Globulin.--The best evidence at hand thus far 
indicates that the liver is of primary importance in the formation, storage, and 
exchange of plasma protein.  Fibrinogen,  and probably the albumins, are pro- 
duced only by the liver cells (24). 
Abnormal levels of circulating plasma protein are reached only when the 
protein stores, chiefly in the liver, are decreased.  The normal animal, depleted 
of its protein stores,  readily can synthesize albumin, globulin, and fibrinogen 
from a proper mixture of amino acids, but those proteins are deposited first in 
the liver and other organs, and do not appear in the plasma until the body stores 
have been reestablished.  In a  damaged liver  the synthesis of protein from 
amino acids  is altered, and the circulating concentrations of plasma protein 
continue to decrease with further hepatic damage.  The disappearance  of the 
hepatic stores of protein with damage to the liver now has been shown both ex- 
perimentally and in human individuals with hepatic cirrhosis (24). 
3.  Cholesterols  and  Cholesterol  Esters.--The  serum  concentration of  total 
cholesterol and the ratio of free to esterified cholesterol in the normal healthy 
animal is maintained within rather narrow  limits.  The esterification  of this 
sterol is accomplished chiefly in the liver, and the ability of the damaged liver to 
perform this function is considerably decreased (25). 
4.  Glucuronic Acid.--It has been demonstrated that several  aromatic com- 
pounds normally  are conjugated  with glucuronic acid and excreted as glucuron- 
ates in the urine.  This conjugation has been considered to be a form of detoxifi- 
cation.  The liver is the chief site both for the synthesis of glucuronic  acid and 
its conjugation to other aromatic compounds.  Livers of rats injured by phos- 
phorus soon lose their capacity to synthesize glucuronic acid (26). 
5.  Phenol and Phenol Esters.--Detailed studies of the metabolism of phenol 
have demonstrated that the synthesis of phenol sulfuric and phenol glucuronic 
acids takes place only in the hepatic parenchyma.  The exclusion of the liver 
from the normal circulation by an Eck fistula eliminates phenol conjugation. 
Likewise extensive liver injury due to various toxic agents always will lessen 
phenol  conjugation.  Extreme  and  fatal hepatic  injury will  reduce phenol 
conjugation to zero (27). 
In conclusion, it would appear that adequate measures were taken to demon- 
strate the possible existence of hepatic insufficiency.  The fact that none of the 
functions studied were altered in the animals indicates that dibenzanthracene is 
not a general  hepatotoxin but, according  to the data thus far available,  ap- 
parently affects particularly that function of the liver which is concerned with 
the metabolism of vitamin A. 
This particular effect of the carcinogen can be obviated to some measure by 160  IIEPATIC VITAMIN A 
the simultaneous administration of large supplements of vitamin A.  This re- 
lationship  between  the  carcinogen and  the  vitamin  therefore suggested  the 
existence of an anchor in the liver to which vitamin A normally is attached and 
which can be competed for by the dibenzanthracene or its metabolites.  Such a 
hypothesis definitely could be proved if it were possible to show that (1) the 
dibenzanthracene-treated  rat  excretes  or  metabolizes  increased  amounts  of 
vitamin A, (2) the hepatic concentration of dibenzanthracene and its metabo- 
lites is a function of the vitamin A simultaneously administered to the animals, 
and (3) that the administration of large supplements of vitamin A results in an 
increased excretion or utilization of dibenzanthracene.  Unfortunately, trust- 
worthy methods for these studies now are not available, though they are under 
investigation in this laboratory (28, 29). 
In contrast to the effect of the carcinogen butter yellow, dibenzanthracene ap- 
parently  does  not  impair  the  hepatic  storage  of  riboflavin.  Furthermore, 
whereas the simultaneous administration of yeast to rats given butter yellow 
prevents the  depletion of riboflavin and diphosphopyridine nueleotide from 
their livers, the administration of yeast did not counteract the ability of di- 
benzanthracene to deplete the hepatic store of vitamin A.  These observations 
thus suggested that different carcinogens selectively inhibit different reactions 
which occur in the liver cells,  and further indicate the particular effect of di- 
benzanthracene on the hepatic metabolism of vitamin A. 
In section B of this study it was noted that the simultaneous administration 
of yeast to the dibenzanthracene-treated rats apparently enhanced the ability 
of the carcinogen to  deplete  the  hepatic  stores  of  vitamin  A.  At  present, 
no explanation for that observation is at hand, but it is conceivable that  the 
effect was an additive one.  Previous studies have shown that the administra- 
tion of yeast to human individuals can increase the plasma levels of vitamin 
A (7), probably by stimulating a release of the vitamin from its hepatic stores. 
Likewise, there is evidence to show that normal rats fed choline, a  substance 
contained in yeast, have abnormally low concentrations of vitamin A in their 
livers (30).  Details of the relationship between choline, yeast, and vitamin A 
at present are under investigation in this laboratory. 
CONCLUSIONS 
1.  The decreased concentrations of vitamin A in the livers of rats given di- 
benzanthracene probably are due to a particular effect of the carcinogen on the 
ability of the liver to store the vitamin and not to the production of general 
hepatic dysfunction. 
2.  The administration of dibenzanthracene to normal rats does not (a) in- 
crease significantly their hepatic content of total fat nor decrease that of phos- 
pholipid; (b)  impair the ability of  their  livers  to  fabricate  serum albumin; 
(c)  impair  the  capacity of their livers to esterify cholesterol or phenol;  (d) 
interfere with  the  hepatic  synthesis and  conjugation of glucuronic acid;  or 
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3.  The simultaneous ingestion of yeast by the dibenzanthracene-treated rats 
further depletes their hepatic stores of vitamin A.  This depletion conceivably 
is due to the fact that yeast alone also might deplete the liver of its vitamin A 
and thus a summation of two similar effects is attained. 
4.  The results suggest a competition between vitamin A and dibenzanthra- 
cene for some substance, possibly a protein, to which vitamin A may be bound 
in the liver. 
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